CN101040914B - 一种治疗肾阳亏虚、少腹血瘀的中药组合物及其制备方法 - Google Patents
一种治疗肾阳亏虚、少腹血瘀的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN101040914B CN101040914B CN200710017729XA CN200710017729A CN101040914B CN 101040914 B CN101040914 B CN 101040914B CN 200710017729X A CN200710017729X A CN 200710017729XA CN 200710017729 A CN200710017729 A CN 200710017729A CN 101040914 B CN101040914 B CN 101040914B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- kidney
- blood stasis
- cordyceps
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000008280 blood Substances 0.000 title claims description 47
- 210000004369 blood Anatomy 0.000 title claims description 45
- 239000003814 drug Substances 0.000 title claims description 42
- 150000001875 compounds Chemical class 0.000 title 1
- 210000003734 kidney Anatomy 0.000 claims abstract description 57
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 30
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 30
- 235000008434 ginseng Nutrition 0.000 claims abstract description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000000203 mixture Substances 0.000 claims abstract description 23
- 244000268590 Euryale ferox Species 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000001035 drying Methods 0.000 claims abstract description 7
- 210000000582 semen Anatomy 0.000 claims description 39
- 241000190633 Cordyceps Species 0.000 claims description 30
- 241000208340 Araliaceae Species 0.000 claims description 29
- 235000006487 Euryale ferox Nutrition 0.000 claims description 21
- 239000000843 powder Substances 0.000 claims description 20
- 239000009636 Huang Qi Substances 0.000 claims description 18
- 238000011282 treatment Methods 0.000 claims description 17
- 210000001015 abdomen Anatomy 0.000 claims description 15
- 239000008187 granular material Substances 0.000 claims description 8
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 8
- 239000011812 mixed powder Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 241000545442 Radix Species 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 239000000469 ethanolic extract Substances 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 235000019359 magnesium stearate Nutrition 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 230000007812 deficiency Effects 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 6
- 230000006837 decompression Effects 0.000 abstract description 3
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000233866 Fungi Species 0.000 abstract 1
- 240000001307 Myosotis scorpioides Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 35
- 210000004185 liver Anatomy 0.000 description 23
- 201000001881 impotence Diseases 0.000 description 19
- 201000010099 disease Diseases 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 208000010228 Erectile Dysfunction Diseases 0.000 description 15
- 229940079593 drug Drugs 0.000 description 14
- 230000008901 benefit Effects 0.000 description 13
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 230000003014 reinforcing effect Effects 0.000 description 9
- 239000007789 gas Substances 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 230000002950 deficient Effects 0.000 description 6
- 230000000916 dilatatory effect Effects 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 206010036596 premature ejaculation Diseases 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 206010002660 Anoxia Diseases 0.000 description 4
- 241000976983 Anoxia Species 0.000 description 4
- 206010021143 Hypoxia Diseases 0.000 description 4
- 206010059013 Nocturnal emission Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000007953 anoxia Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000004392 genitalia Anatomy 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 210000000629 knee joint Anatomy 0.000 description 4
- 239000002398 materia medica Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 230000036299 sexual function Effects 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000012201 sexual and gender identity disease Diseases 0.000 description 3
- 208000015891 sexual disease Diseases 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000590428 Panacea Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 210000004100 adrenal gland Anatomy 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000002481 ethanol extraction Methods 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000001456 gonadotroph Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000003899 penis Anatomy 0.000 description 2
- MRBDMNSDAVCSSF-UHFFFAOYSA-N phentolamine Chemical compound C1=CC(C)=CC=C1N(C=1C=C(O)C=CC=1)CC1=NCCN1 MRBDMNSDAVCSSF-UHFFFAOYSA-N 0.000 description 2
- 229960001999 phentolamine Drugs 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001625 seminal vesicle Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 201000010653 vesiculitis Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102000015554 Dopamine receptor Human genes 0.000 description 1
- 108050004812 Dopamine receptor Proteins 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000009328 Perro Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 1
- 239000000674 adrenergic antagonist Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000009165 androgen replacement therapy Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 229960004046 apomorphine Drugs 0.000 description 1
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical compound C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 description 1
- 229960002802 bromocriptine Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 210000002149 gonad Anatomy 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 208000031424 hyperprolactinemia Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000006502 papoula Nutrition 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000009118 salvage therapy Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 239000000050 smooth muscle relaxant Substances 0.000 description 1
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000004336 spermatogonium Anatomy 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 150000003515 testosterones Chemical class 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 239000002550 vasoactive agent Substances 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 229960000317 yohimbine Drugs 0.000 description 1
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 1
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710017729XA CN101040914B (zh) | 2007-04-24 | 2007-04-24 | 一种治疗肾阳亏虚、少腹血瘀的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200710017729XA CN101040914B (zh) | 2007-04-24 | 2007-04-24 | 一种治疗肾阳亏虚、少腹血瘀的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101040914A CN101040914A (zh) | 2007-09-26 |
CN101040914B true CN101040914B (zh) | 2010-06-02 |
Family
ID=38806843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200710017729XA Expired - Fee Related CN101040914B (zh) | 2007-04-24 | 2007-04-24 | 一种治疗肾阳亏虚、少腹血瘀的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101040914B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101422570B (zh) * | 2008-12-08 | 2011-09-28 | 济南老来寿生物股份有限公司 | 一种提高男性性功能的功能性食品 |
CN103655682A (zh) * | 2013-12-21 | 2014-03-26 | 山东中大药业有限公司 | 一种治疗阳痿的中药及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1298670A (zh) * | 1999-12-03 | 2001-06-13 | 张超英 | 无尼古丁纯净保健香烟的制作方法 |
CN1660404A (zh) * | 2005-01-19 | 2005-08-31 | 雷小平 | 一种男性养生补肾壮阳保健品 |
-
2007
- 2007-04-24 CN CN200710017729XA patent/CN101040914B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1298670A (zh) * | 1999-12-03 | 2001-06-13 | 张超英 | 无尼古丁纯净保健香烟的制作方法 |
CN1660404A (zh) * | 2005-01-19 | 2005-08-31 | 雷小平 | 一种男性养生补肾壮阳保健品 |
Also Published As
Publication number | Publication date |
---|---|
CN101040914A (zh) | 2007-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101810685B (zh) | 一种治疗膝关节炎症的中药组合物及其制备方法 | |
CN102293874B (zh) | 一种多功能药枕及其制备方法 | |
CN101062080B (zh) | 一种具有抗疲劳作用的药物组合物及其制备方法 | |
CN102526326B (zh) | 用于治疗绝经后骨质疏松症的中药及其制备方法 | |
CN104922543A (zh) | 一种治疗闭经的药物组合物及其制备方法 | |
CN104208418A (zh) | 一种固精缩尿补肾的金樱子保健口服液及其制备方法 | |
CN102716315A (zh) | 一种补肾阳保健药酒及其制备方法 | |
CN101579471B (zh) | 治疗中医消渴证的药物 | |
CN101507776B (zh) | 一种治疗肾虚、腰膝酸软的中药制剂及其制备方法 | |
CN101474361B (zh) | 一种治疗老年呆病和脑梗塞的中药 | |
CN1109554C (zh) | 一种治疗过敏性紫癜病的药 | |
CN101040914B (zh) | 一种治疗肾阳亏虚、少腹血瘀的中药组合物及其制备方法 | |
CN103285211B (zh) | 一种用于治疗病理肥胖的中药颗粒 | |
CN103446423A (zh) | 抗疲劳保健中药 | |
CN102526444A (zh) | 一种补肾壮阳的中药组合物及其制备方法 | |
CN102048913B (zh) | 一种治疗更年期综合症的中药制剂及其制备方法 | |
CN102302668B (zh) | 用于多囊卵巢综合征的药物组合物 | |
CN101224275B (zh) | 一种治疗黄褐斑的中药 | |
CN106361981A (zh) | 一种滋阴壮阳的中药 | |
CN106620133A (zh) | 一种具有补肾壮阳、祛风湿功能的药酒及其制备方法 | |
CN103877375B (zh) | 一种治疗封闭抗体缺乏型反复自然流产的中药及其制备方法 | |
CN104162090B (zh) | 一种药物组合物及其制备方法 | |
CN103340921B (zh) | 一种治疗脾肾阳虚的中药及其制备方法 | |
CN1290554C (zh) | 一种补肾壮阳、益气健脾的药物及其制备方法 | |
CN101085196A (zh) | 一种内服治疗神经衰弱的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090109 Address after: 70, West Avenue, new industrial zone, Xi'an hi tech Zone, Shaanxi, China: 710119 Applicant after: Heer Pharmaceutical Co., Ltd. Address before: 70, West Avenue, new industrial zone, Xi'an hi tech Development Zone, Shaanxi, China: 710119 Applicant before: Xi'an Yizhiliu Pharmaceutical Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: HULL PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: XI'AN YIZHILIU PHARMACEUTICAL CO., LTD. Effective date: 20090109 |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN MEDICINE INST., XI'AN CITY Free format text: FORMER OWNER: HULL PHARMACEUTICAL CO., LTD. Effective date: 20111101 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 710119 XI'AN, SHAANXI PROVINCE TO: 710075 XI'AN, SHAANXI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20111101 Address after: 16 No. 710075, unity South Road, hi tech Industrial Development Zone, Shaanxi, Xi'an Patentee after: Tianjin Medicine Inst., Xi'an City Address before: 710119, No. 70, West Avenue, new industrial park, hi tech Zone, Shaanxi, Xi'an Patentee before: Heer Pharmaceutical Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100602 Termination date: 20170424 |
|
CF01 | Termination of patent right due to non-payment of annual fee |